Securities Code: 300149
Securities Abbreviation: Ruizhi Pharmaceutical
Announcement Number: 2026-36
Ruizhi Pharmaceutical Technology Co., Ltd.
Announcement on Adjusting the Offering Price and Number of Shares for Private Placement
The Company and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Special Reminder:
-
The pricing benchmark date for the Company's private placement of shares in 2024 has been adjusted from "the announcement date of the fifth meeting of the Sixth Board of Directors" to "the first day of the offering period," and the offering price has been adjusted from "RMB 5.27 per share" to "no less than 80% of the average daily trading price of the Company's shares in the 20 trading days prior to the pricing benchmark date." The total number of shares has been adjusted from "no more than 60,019,704 shares (inclusive)" to "determined by dividing the total amount of raised capital by the offering price, not exceeding 60,019,704 shares (inclusive)."
-
Apart from the above adjustments, other matters concerning the Company's private placement of shares remain unchanged.
-
The total amount of capital to be raised by this private placement of shares shall not exceed RMB 316,303,800 (inclusive) (unchanged from before the change), and the number of shares issued shall not exceed the previously planned number of shares to be issued (i.e., no more than 60,019,704 shares). Therefore, the change to this offering plan does not constitute a major change and does not require submission to the shareholders' meeting for deliberation. If the total amount of capital to be raised or the number of shares to be issued in this offering needs to be increased due to subsequent market conditions or regulatory policies, the offering plan shall be re-submitted to the Company's shareholders' meeting for deliberation and approval, and regulatory approval shall be obtained.
Ruizhi Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") held the third meeting of the Sixth Board of Directors, the fifth meeting of the Sixth Board of Directors, the 2024 Annual Shareholders' Meeting, the seventeenth meeting of the Sixth Board of Directors, and the 2025 Annual Shareholders' Meeting on December 13, 2024, April 1, 2025, May 30, 2025, May 18, 2026, and May 28, 2026, respectively, and deliberated and approved the relevant proposals for the Company's private placement of shares.